Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules

Nature Protocols

Volumn 1, Issue 3, 2006, Pages 1477-1480

  Wang, Yi ^a   Liu, Guozheng ^a   Hnatowich, Donald J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOGENIC AMINE; CHELATING AGENT; MERTIATIDE TC 99M;

ARTICLE; CHEMISTRY; ISOTOPE LABELING; METHODOLOGY; SCINTISCANNING;

BIOGENIC AMINES; CHELATING AGENTS; ISOTOPE LABELING; RADIONUCLIDE IMAGING; TECHNETIUM TC 99M MERTIATIDE;

EID: 34248562046     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2006.262     Document Type: Article

References (14)

1. 3 and SHNH-an in vitro and animal in vivo comparison. Nucl. Med. Biol. 23, 917-922 (1996).
2. Blankenberg, F.G., Vanderheyden, J.L., Strauss, H.W. & Tait, J.F. Radiolabeling of HYNIC-annexin V with technetium-99m for in vivo imaging of apoptosis. Nature Protocols 1, 108-110 (2006).
3. 2 chelate conjugated to the antimicrobial peptide UBI 29-41. Nucl. Med. Biol. 31, 503-509 (2004).
4. Bogdanov, A., Jr., Tung, C.-H., Bredow, S. & Weissleder, R. DNA binding chelates for nonviral gene delivery imaging. Gene Ther. 8, 515-522 (2001).
5. Blok, D. et al. New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides. Nucl. Med. Biol. 31, 815-820 (2004).
6. Liu, G. et al. Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting. Appl. Radiat. Isot. 64, 971-978 (2006).
7. Fritzberg, A.R., Kasina, S., Eshima, D. & Johnson, D.L. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J. Nucl. Med. 27, 111-116 (1986).
8. Okarvi, S.M. & Jammaz, I.A. Preparation of in vitro and in vivo evaluation of technetium-(99m)-labeted folate and methotrexate conjugates as tumor imaging agents. Cancer Biother. Radiopharm. 21, 49-60 (2006).
9. Visser, G.W., Gerretsen, M., Herscheid, J.D., Snow, G.B. & Dongen, G. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: A technical protocol. J. Nucl. Med. 34, 1953-1963 (1993).
10. Yoo, T.M. et al. Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment. J. Nucl. Med. 38, 294-300 (1997).
11. Duncan, R.J.S., Weston, P.D. & Wrigglesworth, R. A new reagent which may be used to introduce sulfhydryl-groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem. 132 68-73 (1983).
12. Hnatowich, D.J. et al. Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine. J. Nucl. Med. 39, 56-64 (1998).
13. Vanderheyden, J.L. et al. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice. Nucl. Med. Biol. 33, 135-144 (2006).
14. Winnard, P., Chang, F., Rusckowski, M., Mardirossian, G. & Mnatowich, D.J. Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA. Nucl. Med. Biol. 24, 425-432 (1997).